Passive haemagglutination test for human neurocysticercosis immunodiagnosis: I. Standardization and evaluation of the passive haemagglutination test for the detection of anti-Cysticercus cellulosae antibodies

A passive haemagglutination test (PHA) for human neurocysticercosis was standardized and evaluated for the detection of specific antibodies to Cysticercus cellulosae in cerebrospinal fluid (CSF). For the assay, formaldehyde-treated group O Rh-human red cells coated with the cysticerci crude total saline extract (TS) antigen were employed. A total of 115 CSF samples from patients with neurocysticercosis was analysed, of these 94 presented reactivity, corresponding to 81.7% sensitivity, in which confidence limit of 95% probability (CL95%) ranged from 74.5% to 88.9%. Eighty-nine CSF samples derived from individuals of control group presented as nonreactive in 94.4% (CL95% from 89.6% to 99.2%). The positive and negative predictive values were 1.4% and 99.9%, respectively, considering the mean rate of that this assay provide a rapid, highly reproducible, and moderately sensitive mean of detecting specific antibodies in CSF samples.

Saved in:
Bibliographic Details
Main Authors: Ueda,Mirthes, Camargo,Eide Dias, Vaz,Adelaide José, Souza,Ana Maria Carvalho de, Figueiredo,Regina Maria, Silva,Marcos Vinicius da
Format: Digital revista
Language:English
Published: Instituto de Medicina Tropical de São Paulo 1988
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651988000100009
Tags: Add Tag
No Tags, Be the first to tag this record!